Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services

Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services
Innovative technology fosters collaboration and expedites access to critical R&D information

PHILADELPHIA, and LONDON, Feb. 28, 2012 /PRNewswire via COMTEX/ -- Thomson Reuters announced the availability of Cortellis for Informatics, a new capability that speeds access to critical life sciences research and development information found on its premiere life sciences platform, Thomson Reuters Cortellis.

Cortellis for Informatics uses sophisticated application programming interfaces (APIs) to enhance the research and development process by delivering real-time access to powerful information and tools for biopharmaceutical competitive intelligence, drug pipeline, and drug research and development.

Each API integrates Thomson Reuters data with proprietary content and public information sources into a comprehensive view that is customized to meet the needs of a company, team or individual researcher. With Cortellis for Informatics, data can be shared in a number of ways, including dashboards, custom reports and alerts, and intranet and mobile applications.

"We worked closely with Thomson Reuters during their development and testing phases, and I am delighted to say that the Cortellis APIs exceed my expectations and allow us to take advantage of Thomson Reuters content in the systems that drive our business," said Dr. William Hayes, director of Decision Support at Biogen Idec.

"For life sciences professionals, Cortellis for Informatics is a significant step forward," said Wendy Hamilton, senior vice president at Thomson Reuters. "The advanced options for obtaining information give customers access to our content beyond Cortellis' highly intuitive web portal. Information can now be incorporated directly on the user's preferred systems, customized to their needs, creating additional opportunities for integration across the entire organization."

Cortellis for Informatics streamlines information sharing across all levels of the organization. Instead of using multiple systems to manage workflows, researchers access up-to-the-minute news in the office, in meetings or at the bench. This ability to deploy high-quality Thomson Reuters information across the whole company in real time within internal systems provides greater opportunities for collaboration in the scientific search and discovery process.

Cortellis for Informatics provides web services for investigational drugs, drug targets, ontologies, patents, clinical trials and analytics.

For more information on Cortellis, visit cortellis.thomsonreuters.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com .

SOURCE Thomson Reuters

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.